{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T04:48:02Z","timestamp":1781671682972,"version":"3.54.5"},"reference-count":7,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Neurol"],"published-print":{"date-parts":[[2023,9,1]]},"abstract":"<jats:p>This Viewpoint describes the relevance of sex-specific differences in the treatment of migraine, including in evidence from trials of CGRP therapeutics, and the clinical implications for decision-making in practice and trial design.<\/jats:p>","DOI":"10.1001\/jamaneurol.2023.2335","type":"journal-article","created":{"date-parts":[[2023,7,24]],"date-time":"2023-07-24T15:33:29Z","timestamp":1690212809000},"page":"885","source":"Crossref","is-referenced-by-count":23,"title":["Considering Patient Sex in Prescribing CGRP Receptor Antagonists for Short-Term Treatment of Migraine"],"prefix":"10.1001","volume":"80","author":[{"given":"Frank","family":"Porreca","sequence":"first","affiliation":[{"name":"Department of Pharmacology, University of Arizona, Tucson"},{"name":"Mayo Clinic Arizona, Phoenix"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Dodick","sequence":"additional","affiliation":[{"name":"Mayo Clinic Arizona, Phoenix"},{"name":"Atria Academy of Science and Medicine, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"632","key":"nvp230010r1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abj8186","article-title":"Spatial transcriptomics of dorsal root ganglia identifies molecular signatures of human nociceptors.","volume":"14","author":"Tavares-Ferreira","year":"2022","journal-title":"Sci Transl Med"},{"issue":"22","key":"nvp230010r2","doi-asserted-by":"publisher","first-page":"4323","DOI":"10.1523\/JNEUROSCI.0364-19.2019","article-title":"Dural calcitonin gene-related peptide produces female-specific responses in rodent migraine models.","volume":"39","author":"Avona","year":"2019","journal-title":"J Neurosci"},{"issue":"10","key":"nvp230010r3","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1523\/JNEUROSCI.1137-21.2022","article-title":"A female-specific role for calcitonin gene-related peptide (CGRP) in rodent pain models.","volume":"42","author":"Paige","year":"2022","journal-title":"J Neurosci"},{"issue":"1","key":"nvp230010r4","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/(ISSN)1531-8249","article-title":"The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats.","volume":"33","author":"Goadsby","year":"1993","journal-title":"Ann Neurol"},{"issue":"1","key":"nvp230010r5","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s10194-018-0927-2","article-title":"Migraine induction with calcitonin gene-related peptide in patients from erenumab trials.","volume":"19","author":"Christensen","year":"2018","journal-title":"J Headache Pain"},{"key":"nvp230010r6","unstructured":"US Food and Drug Administration, Center for Drug Evaluation and Research. Clinical review of ubrogepant, new drug application (NDA) 211765Orig1s000. December 19, 2019. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2019\/211765Orig1s000MedR.pdf"},{"key":"nvp230010r7","unstructured":"US Food and Drug Administration, Center for Drug Evaluation and Research. Clinical review of rimegepant, new drug application (NDA) 212728Orig1s000. February 18, 2020. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2020\/212728Orig1s000OtherR.pdf"}],"container-title":["JAMA Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/articlepdf\/2807206\/jamaneurology_porreca_2023_vp_230010_1694018354.83841.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T15:01:49Z","timestamp":1694444509000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/fullarticle\/2807206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,1]]},"references-count":7,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaneurol.2023.2335","relation":{},"ISSN":["2168-6149"],"issn-type":[{"value":"2168-6149","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9,1]]}}}